Albemarle Corporation

New York Stock Exchange
Back to all articles
Slightly Bullish +25

Albemarle Corp. stock falls on lithium demand worries as guidance stays intact

AI-generated analysis

📉 Albemarle Corp. shares dropped 3.6% to $110.91 on September 18, 2026, extending a year-to-date decline of 21.5% amid lithium demand worries.

💰 The company reaffirmed its 2026 sales guidance range of $5.70 billion to $6.00 billion despite the challenging market environment.

📊 Analyst consensus remains 'Moderate Buy' with an average price target of $190.04, suggesting significant upside from current levels.

⚠️ Rothschild and Co lowered its price target to $170.00 with a Neutral rating, signaling caution on near-term lithium trends.

📅 Investors await the November 4, 2026 earnings call for updates on revenue progress within the established guidance band.

🏢 Albemarle maintains its status as a mid-cap constituent of the S&P 500 within the materials and specialty chemicals sector.

Bullish Signals
  • The company has maintained its full-year 2026 sales guidance range of $5.70 billion to $6.00 billion, demonstrating management confidence in growth despite short-term price headwinds.
  • Analyst consensus remains 'Moderate Buy' with an average price target of $190.04, implying substantial upside potential from the recent trading price of approximately $111.
Risk Factors
  • Shares fell 3.6% to close at $110.91 on September 18, 2026, reflecting a year-to-date decline of 21.5% driven by weaker lithium prices and EV demand concerns.
  • Rothschild and Co recently lowered its price target from $188.00 to $170.00 with a Neutral rating, indicating greater caution regarding valuation and near-term market trends.
Full Analysis
Albemarle Corp. (ALB) shares declined 3.6% to close at $110.91 on September 18, 2026, marking a significant year-to-date drop of 21.5% as the stock fell from its opening level of $141.43. The decline was driven by sector-wide concerns regarding weakening lithium prices and potential softness in electric vehicle demand, causing peer producers like SQM and the Global X Lithium ETF to also slide. Despite the short-term price pressure and negative market sentiment surrounding the commodity cycle, Albemarle has maintained its full-year 2026 sales guidance range of $5.70 billion to $6.00 billion. This reaffirmation suggests management remains confident in achieving mid- to high-single-digit growth trajectories for the year, even as current lithium market conditions challenge immediate revenue realization. Analyst sentiment toward Albemarle remains broadly positive with a consensus 'Moderate Buy' rating from 15 analysts, though some caution has emerged. The average analyst price target stands at $190.04, implying substantial upside potential from the recent trading levels around $111. Investors are now focused on the upcoming earnings report scheduled for November 4, 2026, to see if management can bridge the gap between current stock prices and these higher valuation targets.